Iatrogenic hypoglycemia causes recurrent morbidity in most people with type 1 diabetes and
many with type 2 diabetes, and it is sometimes fatal. The barrier of hypoglycemia generally …

We examined the in vivo metabolic effects of vanadyl sulfate (VS) in non-insulin-dependent
diabetes mellitus (NIDDM). Six NIDDM subjects treated with diet and/or sulfonylureas were …

We infused epinephrine, glucagon, and cortisol in combination into health y overnight-fasted
subjects in doses designed to simulate changes in severe stress. Whenall three hormones …

Nineteen patients with insulin-dependent diabetes mellitus were evaluated for overall reliability
of self-generated data from capillary blood glucose monitoring. For a period of 12 to 14 …

We compared the effects of oral vanadyl sulfate (100 mg/day) in moderately obese NIDDM
and nondiabetic subjects. Three-hour euglycemic-hyperinsulinemic (insulin infusion 30 mU · …

OBJECTIVE: To investigate the effect of 3-months’ daily administration of high doses of
sucralose, a non-nutritive sweetener, on glycemic control in subjects with type 2 diabetes. …

Iatrogenic hypoglycemia causes recurrent physical and recurrent or even persistent
psychosocial morbidity, and some mortality, in patients with insulindependent diabetes mellitus (…

Eighty-four persons with insulin-dependent diabetes participated in this study to determine
whether glycemic control was related to personality, anxiety, depression, and/or quality of life. …

We evaluated the effect of antecedent hypoglycemia on glucose counterregulation during
hypoglycemia in nondiabetic human subjects. In single hypoglycemia studies, glucose …

Context: The common P12A polymorphism in PPARG (a target for thiazolidinedione
medications) has been consistently associated with type 2 diabetes. Objective: We examined …